Atypical parkinsonian syndromes;Atypische Parkinson-Syndrome

Nervenarzt

Volumn 68, Issue 2, 1997, Pages 102-115

  Wenning, G K ^a,c   Pramstaller, P P ^b   Ransmayr, G ^a   Poewe, W ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b A Llgemeines Regionalkrankenhaus   (Italy)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

corticobasal degeneration; idiopathic Parkinson's disease; multiple system atrophy; progressive supranuclear palsy

Indexed keywords

APRAXIA; EXTRAPYRAMIDAL SYNDROME; HUMAN; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME;

BRAIN; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY;

EID: 0030904013     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050104     Document Type: Review

References (142)

1. Abbruzzese G, Marchese R, Trompetto C (1997) Sensory and motor evoked potentials in mulitple system atrophy: a comparative study Parkinson's disease. Mov Disord (im Druck)
2. Abe H, Yagishita S, Amano N, Iwabuchi A, Hasegawa K, Kowa K (1992) Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study. Acta Neuropathol 84: 273-277
3. Adams RD, van Bogaert L, van der Hecken H (1961) Dégénérescences nigro-striées et cérébello-nigro-striees. Psychiat Neurol 142: 219-259
4. Albert ML, Feldmann RG, Willis AL (1974) The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 91-130
5. Aldrich MS, Forster NL, White RF, Bluemlein L, Prokopowicz G (1989) Sleep abnormalities in progressive supranuclear palsy. Ann Neurol 25: 577
6. Beck RO, Betts CD, Fowler CJ (1994) Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 151: 1336-1341
7. Blin J, Baron JD, Dubois B, Pillon B, Cambon H, Gambier J, Agid Y (1990) Positron emission tomography in progressive supranuclear palsy. Arch Neurol 47: 747-752
8. Blin J, Horwitz B, Baron J, Agid Y (1995) Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction? Eur J Neurol 1: 221-228
9. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RSJ (1990) Differing patterns of striatal 18-F-Dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 28: 547-555
10. Brooks DJ, Salmon EP, Mathias CJ, Quinn N, Leenders KL, Bannister R, Marsden CD, Frackowiak RSJ (1990) The relationhip between locomotor disability, autonomie dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomie failure, and Parkinson's diseare, studied with PET. Brain 113: 1539-1552
11. Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak R (1992) Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11-C-raciopride and positron emission tomography. Ann Neurol 31: 84-192
12. Brunt ERP, van Weerden TW, Pruim J, Lakke JWPF (1995) Unique myoclonic pattern in corticobasal degeneration. Mov Dis 10: 132-142
13. Brusa A, Mancardi GL, Bugiani O (1978) Progressive supranuclear palsy: an overview. Ital J Neurol Sci 1: 205-222
14. Burn DJ, Mathias CJ, Quinn N et al (1993) Striatal opiate receptor binding in Parkinson's disease and multiple system atrophy: 11 C-Diprenorphine study. Neurology 43 [Suppl]: 454
15. Clark AW, Manz HJ, Withe CL, Lehman J, Miller D, Coyle JT (1986) Cortical degeneration with swollen chromatolytic neurons: in relationship to Pick's disease. J Neuropathol Exp Neurol 45: 268-284
16. Colosimo C, Albanese A, Hughes AJ, de Bruin V, Lees A (1995) Some specific clinical features differentiale multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 55: 294-298
17. Colosimo C, Merello M, Pontieri F (1996) Amantadine in parkinsonian patients unreponsive to levodopa: a pilot study. J Neurol 243: 422-425
18. Costa C, Duyckaerts C, Cervera P, Hauw JJ (1992) Les inclusions oligodendriales, un marqueur des atrohies multisystématisées. Rev Neurol 148: 274-280
19. Daniel SE (1992) The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias C (eds) Autonomie failure. A textbook of clinical disorders of the autonomie nervous system, 3rd edition. Oxford University Press, Oxford, pp 584-585
20. Daniel SE, Geddes JF, Revesz T (1995) Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 262
21. Daniel SE, de Bruin VMS, Lees AJ (1995) The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 118: 759-770
22. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, McDonald WI, Marsden CD, Miller DH (1995) Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 37: 204-210
23. De Bruin VMS, Lees AJ (1992) The clinical features of 67 patients with clinically definite Steele-Richardson-Olszewski syndrome. Behavioural Neurology 5: 229-232
24. De Bruin VMS, Lees AJ (1994) Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olzsewski and other related syndromes: a review of 90 pathologically verified cases. Mov Dis 9: 381-389
25. Dehaene I (1984) Apraxia of eyelid opening in progressive supranuclear palsy. Ann Neurol 15: 115
26. Dejerine J, Thomas AA (1900) L'atrophie olivo-ponto-cerebelleuse. Nouv Iconog de le Salpetriere 13: 330-370
27. De Voider AG, Francart J, Laterre C, Dooms G, Bol A, Michel C, Goffinet AM (1989) Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann Neurol 26: 239-247
28. Dix MR, Harrison MJG, Lewis PD (1971) Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrom): a report of nine cases with particular reference to the mechanism of the oculomotor disorder. J Neurol Sci 13: 237-256
29. Dubas F, Gray F, Escourolle R (1983) Maladie de Steele-Richardson-Olszewski sans ophthalmoplegie. Rev Neurol 139: 407-416
30. Eardley I, Quinn NP, Fowler CJ, Kirby RS, Parkhouse HM, Marsden CD, Bannister R (1989) The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol 64: 360-362
31. Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Powers JM (1991) The metabolic landscape of cortico-basalganglionic degeneration with positron emission tomography. J Neurol Neurosurg Psychiatry 54: 856-862
32. Eidelberg D, Takikawa S, Moeller JR, Dhagwan V, Redington K, Chaly T, Robeson W, Dahl JR, Mergouleff D, Fazzini E, Przedborski S, Fahn S (1993) Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 33: 518-527
33. Feifel E, Brenner M, Teiwes R, Lucking CH, Deuschl G (1994) Kortikobasale Degeneration. Die Bedeutung klinischer Kriterien zur Diagnosestellung. Nervenarzt 65: 653-659
34. Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe R (1988) Cerebral hypometabolism in progressive supranuclear palsy studied by positron emission tomography. Ann Neurol 24: 399-406
35. Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112: 1171-1192
36. Goffinet AM, De Voider AG, Gillian C, Rectem D, Bol A, Michel C, Cogneau M, Labar D, Laterre C (1989) Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol 25: 131-139
37. Golbe LI, Davis PH, Schonberg BS, Duvoisin RC (1988) Prevalence and natural history of progressive supranuclear palsy. Neurology 38: 1031-1034
38. Gouder-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y (1995) "Pure" striatonigral degeneration and Parkinson's disease: a comparative study. Mov Dis 10: 288-294
39. Graham JG, Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32: 28-34
40. Gresty MA, Ell J (1982) Normal modes of head-eye coordination and the symptomatology of their disorders. In: Lennerstrand G, Yee DS, Keller EL (eds) Functional basis of ocular motility disorders. Pergamon Press, Oxford, pp 391-405
41. Hauw JJ, Daniel SE, Dickson D, Horpoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan IJ (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019
42. Herrlinger K, Wagner-Manslau C, Cebalios-Baumann AO, Weindl A (1992) 123-I-iodobenzamide-SPECT dopamine D2 receptor imaging in normals, patients with Parkinson's disease and other akinetic-rigid syndromes. Mov Dis 7 [Suppl 1]: 146
43. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nu-cleus in Parkinson's disease and in progressive supranuclear palsy. Proc Natl Acad Sci 84: 5976-5980
44. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
45. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ (1992) The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 55: 1009-1013
46. Jackson JA, Jankovic J, Ford J (1983) Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 13: 273-278
47. Jankovic J (1983) Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy. Neurology 33: 505-507
48. Jankovic J (1984) Apraxia of eyelid opening in progressive supranuclear palsy. Ann Neurol 15: 115-116
49. Jankovic J, Friedman D I, Pirozzolo FJ, MaCrary JA (1990) Progressive supranuclear palsy: Motor, neurobehavioural, and neuro-ophthalmological findings. Adv Neurol 53: 293-304
50. Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186-1194
51. Jellinger KA, Bancher C (1992) Neuropathology. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, New York, pp 137-152
52. Joachim CL, Morris JH, Kosik KS, Seldoe DJ (1985) Tau antisera recognize neuro fibrillary tangles in a range of neurodegenerative disorders. Ann Neurol 18: 523-529
53. Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41: 25-30
54. Kato S, Nakamura H (1990) Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructrual studies. Acta Neuropathol 79: 584-594
55. Klockgether T, Faiss J, Poremba M, Dichgans J (1990) The development of infratentorial atrophy in patients with idiopathic cerebellar ataxia of late onset: a CT study. J Neurol 237: 420-423
56. Konagaya M, Konagaya Y, Iida M (1994) Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J Neurol Neurosurg Psychiatry 57: 1528-1531
57. Krack P, Marion MH (1994) "Apraxia of lid opening". A focal eyelid dystonia: Clinical study of 32 patients. Mov Dis 9: 610-615
58. Kristensen MO (1985) Progressive supranuclear palsy-20 years later. Acta Neurol Scand 71: 177-189
59. Kvale JN (1982) Amitryptiline in the management of progressive supranuclear palsy. Arch Neurol 39: 387-388
60. Lang AE, Marsden CD (1983) Eye movement disorders in basal ganglia disorders. In: Rose FC (ed) The eye in general medicine. Chapman and Hall, London, pp 208-284
61. Lang AE, Curran T, Provias J, Bergeron C (1994) Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci 21: 311-318
62. Lees AJ (1987) The Steele-Richardson-Olszewski syndrom (progressive supranuclear palsy). In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworths-Heinemann, London, pp 272-287
63. Lees AJ (1992) The treatment of multiple system atrophy. In: Bannister R, Mathias C (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, pp 646-655
64. Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD (1994) The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 37: 455-459
65. Lippa CF, Smith TW, Fontneau N (1990) Corticonigral degeneration with neuronal achromasia: a clinipathological study of two cases. J Neurol Sci 98: 301-310
66. Lippa CF, Cohen R, Smith TW, Drachman DA (1991) Primary progressive aphasia with focal neuronal achromasia. Neurology 41: 882-886
67. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri RK, Pearce RKB (1996) Natural history of progressive supranuclear palsy (SteeleRichardson-Olszewski syndrome) and clinical predictors of survical: a clinicopathological study. J Neurol Neurosurg Psychiatry 61: 615-620
68. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri RK, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46: 922-930
69. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1-9
70. Litvan I, Hauw JJ, Bartko JJ et al (1996) Validity and reliability of the neuropathologic preliminary criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97-105
71. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning G, Brandel JP, Lai EC, Verny M, Chaudhuri RK, McKee A, Jellinger K, Pearce RKB, Bartko JJ (1997) Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology (im Druck)
72. Magalhäes M, Wenning GK, Daniel SE, Quinn NP (1995) Autonomie dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease - a retrospective comparison. Acta Neurol Scand 91: 98-102
73. Maher ER, Lees AJ (1986) The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 36: 1005-1008
74. Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw J, Agid Y (1991) Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation. Neurology 41: 1593-1597
75. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC (1995) Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; Comparison with Parkinson's disease and normal controls. Mov Dis 10: 179-187
76. Messert B, Van Nuis C (1966) A syndrome of paralysis of downward gaze, dysarthria, pseudobulbar palsy, axial rigidity of neck and trunk, and dementia. J Nerv Ment Dis 143: 47-53
77. Mochizuki A, Mizusawa H, Ohkoshi N, Yoshizawa K, Komatsuzaki Y, Inoue K, Kanazawa I (1992) Argentophilic intracytoplasmic inclusions in multiple system atrophy. J Neurol 239: 311-316
78. Morris JC, Drazner M, Fulling K, Grant E, Golding J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol 46: 651-656
79. Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1990) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 49: 521-530
80. Nishimura M, Namba y, Ikeda K, Oda M (1992) Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranzclear palsy. Neurosci Lett 143: 35-38
81. Nygaard TG, Duvoisin RC, Manocha M, Chokroverty S (1989) Seizures in progressive supranuclear palsy. Neurology 39: 138-140
82. Obeso JA, Rothwell J, Marsden CD (1985) The spectrum of cortical myoclonus. Brain 108: 193-224
83. Ormerod IEC, Harding AE, Miller DH, Johnson G, MacManus D, du Boulay EPG, Kendall BE, Moseley IF, McDonald WI (1994) Magnetic resonance imaging in degenerative ataxic disorders. J Neurol Neurosurg Psychiatry 57: 51-57
84. Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy Drager syndrome). J Neurol Sci 94: 79-100
85. Papp MI, Lantos PL (1992) Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107: 172-82
86. Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117: 235-243
87. Penney JB (1995) Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease. Ann Neurol 37: 553-554
88. Perkin GD, Lees AJ, Stern GM, Kocen RS (1978) Problems in the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Can J Neurol Sci 5: 167-173
89. Pfaffenbach D, Layton DD, Kearns TP (1972) Ocular manifestations in progressive supranuclear palsy. Am J Ophthalmol 74: 1179-84
90. Pierrot-Deseilligni C, Rivaud S, Pillon B, Fournier E, Agid Y (1989) Lateral visually guided saccades in progressive supranuclear palsy. Brain 126: 13-19
91. Pillon B, Dubois B, Lhermitte F, Agid Y (1986) Heterogenity of cognitive impairment in progressive supranuclear palsy. Parkinson's disease and Alzheimer's disease. Neurology 36: 1179-1185
92. Pillon B, Deweer B, Michon A, Malapani C, Agid Y, Dubois B (1994) Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's disease. Neurology 44: 1264-1270
93. Pirani D, Bressi S, Testa D, Grassi F, Cortelli P, Gentrini S, Savoiardo M, Caraceni T, Fazio F (1995) Clinical/meta-bolic correlations in multiple system atrophy. Arch Neurol 52: 179-185
94. Posey WC (1904) Paralysis of upward movement of the eyes. Ann Ophthalm 13: 523-529
95. Pramstaller PP, Wenning GK, Smith SJ, Beck RO, Quinn NP, Fowler CJ (1995) Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 618-621
96. Prasher D, Bannister R (1986) Brain stem auditory evoked potentials in patients with multiple system atrophy with progressive autonomie failure (Shy-Drager syndrome). J Neurol Neurosurg Psychiatry 49: 278-289
97. Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH (1988) Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol 77: 61-68
98. Quinn N (1989) Multiple system atrophy - the nature of the beast. J Neutrol Neurosurg Psychiatry [Suppl] 52: 78-89
99. Quinn N (1994) Multiple system atrophy. In: Marsden CD, Fahn S (eds) Movement Disorders 3. ButterworthsHeinemann, London, pp 262-281
100. Quinn N, Wenning G (1995) Multiple system atrophy. Curr Op Neurol 8: 323-326
101. Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in Parkisonism - a prospective study. Can J Neurol Sci 18: 275-278
102. Rascol O, Sabatini U, Simonetta-Moreau M, Montastruc JL, Rascol A, Clanet M (1991) Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 54: 599-602
103. Rascol O, Sabatini U, Fabre N, Senard JM, Simonetta-Moreau M, Montastruc JL, Clanet M, Rascol A (1995) Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease. Mov Dis 10: 163-170
104. Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33
105. Riley DE, Lang AE, Lewis MB, Resch L, Ashby P, Hornykiewicz O, Black S (1990) Cortico-basal ganglionic degeneration. Neurology 40: 1203-1212
106. Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration: a clinical study of 36 cases. Brain 117: 1183-1196
107. Rinne JO, Burn DJ, Mathias CJ, Quinn NP, Marsden CD, Brooks D (1995) Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol 37: 568-573
108. Savoiardo M, Girotti F, Strada L, Cieri E (1994) Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm [Suppl] 42: 93-110
109. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RSI (1991) Corticobasal degeneration. A unique pattern of regional cortical oxygen hypomentabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 114: 541-556
110. Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W (1993) Correlation of clinical response in apomorphine test with D-2 receptor status as demonstrated by 123-1 IBZM-SPECT. Mov Dis 8: 453-458
111. Schulz JB, Klockgether T, Petersen D, Jauch M, Müller-Schauenburg W, Spieker S, Voigt K, Dichgans J (1994) Multiple system atrophy: natural history. MRI morphology, and dopamine receptor imaging with 123 IBZMSPECT. J Neurol Neurosurg Psychiatry 57: 1047-1056
112. Schwarz J, Tatsch K, Arnold G, Gasser T, Trenkwalder C, Kirsch CM, Oertel WH (1992) 123 I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 42: 556-561
113. Schwarz J, Weis S, Kraft E et al (1996) Signal changes on MRI and icreases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 60: 98-101
114. Shinotoh H, Inoue O, Hirayama K, Aotsuka A, Asahina M, Suhara T, Yamazaki T, Tateno Y (1993) Dopamine Dl receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 56: 467-472
115. Shy GM, Drager GA (1960) A neurological syndrome associated with orthostatic hypotension. Arch Neurol 2: 511-527
116. Smith Doody R, Jankovic J (1992) The alien limb and related signs. J Neurol Neurosurg Psychiatry 55: 806-810
117. Stacy M, Jankovic J (1992) Differential diagnosis of Parkinson's disease and the Parkinsonism Plus syndromes. Neurol Clin 10: 341-359
118. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333-358
119. Steele JC (1972) Progressive supranuclear palsy. Brain 95: 693-704
120. Stell R, Bronstein AM (1994) Eye abnormalities in extrapyramidal diseases. In: Marsden CD, Fahn S (eds) Movement disorders 3. Butterworth-Heinemann, London, pp 88-113
121. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossmann RI (1989) Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39: 1524-1526
122. Thompson PD, Day BL, Rothwell JC, Brown P, Britton T, Marsden CD (1994) The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 117: 1197-1207
123. Tolosa E, Valldeoriola F, Martl MJ (1994) Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). In: Tolosa E, Duvoisin R, Cruz-Sanchez FF (eds) Progressive supranuclear palsy: diagnosis, pathology and treatment. Springer, Wien New York, pp 15-31
124. Troost BT, Daroff RB (1977) The oculomotor defects in progressive supranuclear palsy. Ann Neurol 2: 397-403
125. Vallderiola F, Valls-Solé F, Marti MJ, Tolosa ES (1995) Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Dis 10: 550-555
126. Vidailhet M, Rothwell JC, Thompson PD, Lees AJ, Marsden CD (1992) The auditory startle response in the SteeleRichardson-Olszewski syndrome and Parkinson's disease. Brain 115: 1181-1192
127. Vidailhet M, Rivaud S, Gouider-Khouja N et al (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35: 420-426
128. Watts RL, Mirra SS, Richardson EP (1994) Corticobasal ganglionic degeneration. In: Marsden CD, Fahn S (eds) Movement disorders 3. ButterworthHeinemann, Oxford, pp 282-299
129. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994) Clinical features and natural history of multiple system atrophy. An analysis of 100 patients. Brain 117: 835-845
130. Wenning GK, Smith SJM, Quinn NP (1994) Visual evoked responses in multiple system atrophy. New Trends Clin Neuropharm 8: 113
131. Wenning GK, Jäger R, Kendall B, Kingsley D, Daniel SE, Quinn NP (1994) Is cranial computerized tomography (CT) useful in the diagnosis of multiple system atrophy? Mov Dis 9: 333-336
132. Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE (1994) "Minimal change" multiple system atrophy. Mov Dis 9: 161-166
133. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NO (1995) A clinicopathological study of multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 160-166
134. Wenning GK, Quinn NP (1996) Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov Dis 11: 107-109
135. Wenning GK, Tison F, Elliot L, Quinn NP, Daniel SE (1996) Olivopontocerebellar atrophy in multiple system atrophy. Mov Dis 11: 157-162
136. Wenning GK, Granata R, Laboyrie PML et al (1996) Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Dis 11: 522-532
137. Wenning GK, Kraft E, Beck R, Fowler CJ, Mathias CJ, Quinn NP, Harding AE (1997) Cerebellar presentation of multiple system atrophy. Mov Dis (im Druck)
138. Wenning GK, Smith SJM (1997) Magnetic brain stimulation in multiple system atrophy. Mov Dis (im Druck
139. Wenning GK, Ben Shlomo Y, Tison F, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 cases. Mov Dis (im Druck)
140. Wessel K, Huss G-P, Brueckmann H et al (1993) Follow-up of neurophysiological tests and CT in late-onset cerebellar ataxia and multiple system atrophy. J Neurol 240: 168-176
141. Young A (1985) Progressive supranuclear palsy: post mortem chemical analysis. Ann Neurol 18: 521-522
142. Zweig RM, Whitehouse PJ, Casanova MF, Walker LC, Jankel WR, Price DI (1987) Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann Neurol 22: 18-25